Search Results - Elizabeth Hardaker
- Showing 1 - 5 results of 5
-
1
Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionality by Melanie Grandits, Lais C. G. F. Palhares, Olivia Macleod, John Devlin, Oliver E. Amin, James Birtley, Leanne Partington, Tim Wilson, Elizabeth Hardaker, Sophia N. Karagiannis, Heather J. Bax, Kevin FitzGerald
Published in mAbs (2025-12-01)Get full text
Article -
2
An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities by Lais C. G. F. Palhares, Melanie Grandits, Katie Stoker, Jitesh Chauhan, Heng Sheng Sow, Gilbert O. Fruhwirth, Sophia Tsoka, James Birtley, Leanne Partington, Tim Wilson, Elizabeth Hardaker, Sophia N. Karagiannis, Heather J. Bax, Kevin FitzGerald
Published in Journal of Experimental & Clinical Cancer Research (2025-02-01)Get full text
Article -
3
Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors by Elizabeth Hardaker, Rebecca Adams, Melanie Grandits, Jacobo López-Abente, Heather J Bax, Sophia N Karagiannis, Kristina M Ilieva, Sophia Tsoka, Lais C G F Palhares, Gabriel Osborn, Jitesh Chauhan, Katie Stoker, Heng Sheng Sow, Alex J McCraw, Alicia Chenoweth, Sofia Vlasova, James Birtley, Kevin FitzGerald
Published in Journal for ImmunoTherapy of Cancer (2025-03-01)Get full text
Article -
4
877 Intermittent dosing of the ataxia telangiectasia and Rad3-related (ATR) inhibitor ceralasertib promotes antitumor immunity by remodelling the tumor immune microenvironment in p... by Matthew King, Dmitry Gabrilovich, Simon Barry, Mark Cobbold, Viia Valge-Archer, Adina Hughes, Elizabeth Hardaker, Alison Peter, Anisha Solanki, Lukasz Magiera, Gozde Kar, Stephen Fawell, Ankur Karmokar, Marta Milo, Chrysiis Michaloglou, Ricardo Miragaia, Sara Talbot, Carolyn Lam, Daniel Sutton, Scott Hoffmann, Larissa Carnevalli, Zena Wilson, Alan Lau
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
5
Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models by Brajesh P. Kaistha, Gozde Kar, Andreas Dannhorn, Amanda Watkins, Grace Opoku-Ansah, Kristina Ilieva, Stefanie Mullins, Judith Anderton, Elena Galvani, Fabien Garcon, Jean-Martin Lapointe, Lee Brown, James Hair, Tim Slidel, Nadia Luheshi, Kelli Ryan, Elizabeth Hardaker, Simon Dovedi, Rakesh Kumar, Robert W. Wilkinson, Scott A. Hammond, Jim Eyles
Published in Cancer Biology & Therapy (2024-12-01)Get full text
Article
